Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Zafirlukast (Accolate) and montelukast (Singulair) are both leukotriene receptor antagonists used to control asthma, but they have some key differences. Zafirlukast is taken twice a day on an empty stomach, while montelukast is taken once a day and can be taken with or without food. Montelukast is also used for treating year-round and seasonal allergies and preventing exercise-induced asthma, whereas zafirlukast is not. Montelukast is available in various forms, including chewable tablets and granules, while zafirlukast is only available as a tablet. Additionally, montelukast has been associated with serious mental health side effects, such as aggressive behavior and suicidal thoughts, which are not commonly reported with zafirlukast. Both medications are available in generic forms, making them more affordable options.
Zafirlukast (Accolate) is used to help control symptoms of asthma in people age 5 years and older. It's a tablet that you take by mouth two times every day. This medication helps improve lung function over time; it's not a rescue inhaler so it isn't used when you're having an asthma attack. The most common side effect of zafirlukast (Accolate) is headache. It's available as both a brand-name and generic medication.
Summary for Leukotriene receptor antagonist
Prescription only
Montelukast, the generic for Singulair, is used to help control asthma over time and prevent breathing problems during exercise in both adults and children. It's also used to help relieve allergy symptoms. Montelukast (Singular) comes as tablets, chewable tablets, or oral granules and is usually taken by mouth once a day. Common side effects include upper respiratory infection and headache, and it has a boxed warning for serious mood and behavior changes.
Indications of Zafirlukast vs. Montelukast
Indications for
•Asthma (long-term treatment)
Indications for
•Long-term treatment of asthma - age 12 months and older